| Walker EM, Morrison RG, Dornon L, et al.
Acetaminophen combinations protect against iron-induced cardiac damage in gerbils. [Journal Article, Research Support, Non-U.S. Gov't]
Ann Clin Lab Sci 2009; 39(4):378-85.
Abstract | Full Citation | Find Related Articles | | Warkentin LM, Auriat AM, Wowk S, et al.
Failure of Deferoxamine, an Iron Chelator, to Improve Outcome after Collagenase-induced Intracerebral Hemorrhage in Rats. [JOURNAL ARTICLE]
Brain Res 2009 Oct 29.
Abstract | Full Citation | Find Related Articles | | Viprakasit V, Lee-Lee C, Chong QT, et al.
Iron chelation therapy in the management of thalassemia: the Asian perspectives. [JOURNAL ARTICLE]
Int J Hematol 2009 Oct 29.
Abstract | Full Citation | | Ndong M, Kazami M, Suzuki T, et al.
Iron deficiency down-regulates the Akt/TSC1-TSC2/mammalian Target of Rapamycin signaling pathway in rats and in COS-1 cells. [Journal Article]
Nutr Res 2009 Sep; 29(9):640-7.
Abstract | Full Citation | Find Related Articles | | Hsiao PJ, Wang SC, Wen MC, et al.
Fanconi Syndrome and CKD in a Patient With Paroxysmal Nocturnal Hemoglobinuria and Hemosiderosis. [JOURNAL ARTICLE]
Am J Kidney Dis 2009 Oct 13.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Gordillo G, Fang H, Park HA, et al.
Nox-4 Dependent Nuclear H2O2 Drives DNA Oxidation Resulting in 8-OHdG as Urinary Biomarker and Hemangioendothelioma Formation. [JOURNAL ARTICLE]
Antioxid Redox Signal 2009 Oct 9.
Abstract | Full Citation | Find Related Articles | | Kontoghiorghes GJ, Efstathiou A, Kleanthous M, et al.
Risk/Benefit assessment, advantages over other drugs and targeting methods in the use of deferiprone as a pharmaceutical antioxidant in iron loading and non iron loading conditions. [Journal Article]
Hemoglobin 2009; 33(5):386-97.
Abstract | Full Citation | Find Related Articles | | Chan GC, Chan S, Ho PL, et al.
Effects of chelators (deferoxamine, deferiprone and deferasirox) on the growth of Klebsiella pneumoniae and Aeromonas hydrophila isolated from transfusion-dependent thalassemia patients. [Journal Article]
Hemoglobin 2009; 33(5):352-60.
Abstract | Full Citation | Find Related Articles | | Kontoghiorghes GJ
A New Era in Iron Chelation Therapy: The Design of Optimal, Individually Adjusted Iron Chelation Therapies for the Complete Removal of Iron Overload in Thalassemia and other Chronically Transfused Patients. [Journal Article]
Hemoglobin 2009; 33(5):332-8.
Abstract | Full Citation | Find Related Articles | | Ha SY, Mok AS, Chu WC, et al.
A practical chelation protocol based on stratification of thalassemic patients by serum ferritin and magnetic resonance imaging cardiac t2*. [Journal Article]
Hemoglobin 2009; 33(5):323-31.
Abstract | Full Citation | Find Related Articles |   |
|
| |
Advertise on this site.
|
